Literature DB >> 22939719

Oxytocin and catechol-O-methyltransferase receptor genotype predict the length of the first stage of labor.

Abdullah S Terkawi1, William M Jackson, Mari-Paule Thiet, Shehnaz Hansoti, Rabeena Tabassum, Pamela Flood.   

Abstract

OBJECTIVE: We aimed to identify genetic factors that influence the rate of the first stage of labor. STUDY
DESIGN: We prospectively enrolled 233 laboring nulliparous parturients. Demographic, clinical, and genetic data were collected. We evaluated the influence of population and individual variability using a nonlinear mixed effects model.
RESULTS: Parturients who were homozygous for "G" at oxytocin receptor gene rs53576 transitioned to active labor later and thus had slower labor. Catechol-O-methyltransferase rs4633 genotype TT was associated with slower latent phase labor. Labor induction with prostaglandin was associated with faster labor, and request for meperidine was associated with slower labor. Birthweight was related inversely to the rate of the active phase.
CONCLUSION: There are demographic, clinical, and genetic factors that influence an individual's rate of labor progress. This information could be used in automated form to improve the prediction of the length of the first stage of labor.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22939719     DOI: 10.1016/j.ajog.2012.06.079

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

Review 1.  A Review of the Impact of Obstetric Anesthesia on Maternal and Neonatal Outcomes.

Authors:  Grace Lim; Francesca L Facco; Naveen Nathan; Jonathan H Waters; Cynthia A Wong; Holger K Eltzschig
Journal:  Anesthesiology       Date:  2018-07       Impact factor: 7.892

2.  The association of single-nucleotide polymorphisms in the oxytocin receptor and G protein-coupled receptor kinase 6 (GRK6) genes with oxytocin dosing requirements and labor outcomes.

Authors:  Chad A Grotegut; Emily Ngan; Melanie E Garrett; Marie Lynn Miranda; Allison E Ashley-Koch; Geeta K Swamy
Journal:  Am J Obstet Gynecol       Date:  2017-05-17       Impact factor: 8.661

3.  Effects of breast stimulation for spontaneous onset of labor on salivary oxytocin levels in low-risk pregnant women: A feasibility study.

Authors:  Kaori Takahata; Shigeko Horiuchi; Yuriko Tadokoro; Takuya Shuo; Erika Sawano; Kazuyuki Shinohara
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240

4.  OXTR rs53576 Variation with Breast and Nipple Pain in Breastfeeding Women.

Authors:  Ruth Lucas; Yiming Zhang; Stephen J Walsh; Angela Starkweather; Erin Young
Journal:  Pain Manag Nurs       Date:  2020-12-08       Impact factor: 1.929

Review 5.  Parturition dysfunction in obesity: time to target the pathobiology.

Authors:  Nicole S Carlson; Teri L Hernandez; K Joseph Hurt
Journal:  Reprod Biol Endocrinol       Date:  2015-12-18       Impact factor: 5.211

6.  Oxytocin levels in low-risk primiparas following breast stimulation for spontaneous onset of labor: a quasi-experimental study.

Authors:  Kaori Takahata; Shigeko Horiuchi; Yuriko Tadokoro; Erika Sawano; Kazuyuki Shinohara
Journal:  BMC Pregnancy Childbirth       Date:  2019-10-12       Impact factor: 3.007

7.  Genetic associations of perinatal pain and depression.

Authors:  Lora McClain; Lia Farrell; Kelsea LaSorda; Lisa A Pan; David Peters; Grace Lim
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

8.  Changes in salivary oxytocin after inhalation of clary sage essential oil scent in term-pregnant women: a feasibility pilot study.

Authors:  Yuriko Tadokoro; Shigeko Horiuchi; Kaori Takahata; Takuya Shuo; Erika Sawano; Kazuyuki Shinohara
Journal:  BMC Res Notes       Date:  2017-12-08

9.  Influence of oxytocin receptor single nucleotide sequence variants on contractility of human myometrium: an in vitro functional study.

Authors:  F Füeg; S Santos; C Haslinger; B Stoiber; L Schäffer; E Grünblatt; R Zimmermann; A P Simões-Wüst
Journal:  BMC Med Genet       Date:  2019-11-12       Impact factor: 2.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.